← Open Payments lookup

LAWRENCE TAWIAH: Open Payments

NPI 1508223108 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$958 in 56 payments from 16 companies in 2025. Trend: 2023 $492 · 2024 $649 · 2025 $958

Food & beverage: $958
CompanyPaymentsAmount
Amgen Inc.18$237
Lilly USA, LLC8$172
Novo Nordisk Inc8$149
Takeda Pharmaceuticals U.S.A., Inc.4$63
PFIZER INC.3$62
AstraZeneca Pharmaceuticals LP3$47
Boehringer Ingelheim Pharmaceuticals, Inc.2$39
GlaxoSmithKline, LLC.2$33
Boston Scientific Corporation1$27
Sumitomo Pharma America, Inc.1$23

Products named: MOUNJARO, Wegovy, OTEZLA, REPATHA, EVENITY, TRINTELLIX, ELIQUIS, JARDIANCE.

Industry payments across MD — which companies pay providers there.